STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Clinical trials for STAGE IV PRIMARY PERITONEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PRIMARY PERITONEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PRIMARY PERITONEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost immune system against ovarian cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug called durvalumab to standard chemotherapy is safe and effective for treating advanced ovarian, fallopian tube, or primary peritoneal cancer. It involves 18 patients who have not had prior treatment. The goal is to see if…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
Major trial tests if weekly chemo beats standard schedule for tough cancers
Disease control OngoingThis large, Phase 3 trial aimed to find out if giving a key chemotherapy drug (paclitaxel) once a week is better than giving it once every three weeks for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. All patients also received another standard che…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test Two-Drug attack on tough brain and solid tumors
Disease control OngoingThis early-stage study is testing the safety and best dose of a new oral drug, MLN0128, when given with the existing cancer drug bevacizumab. It is for adults with recurrent glioblastoma (a type of brain tumor) or other advanced solid tumors that have stopped responding to standa…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for recurrent ovarian cancer? early trial tests drug to boost chemo
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib (M6620) to standard chemotherapy (carboplatin and gemcitabine) is safe and might work better for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned. The main goal …
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Hot chemo bath during surgery tested for Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing whether washing the abdomen with heated chemotherapy during cancer-removal surgery is safe and feasible for patients with advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancers. The goal is to see if this approach, sometime…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test new drug to weaken ovarian cancer before surgery
Knowledge-focused OngoingThis early study is testing if a drug called adavosertib, given before surgery, can affect the DNA of tumors in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. The main goal is to learn how the drug changes the cancer cells at a molecular level, whic…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC